{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:59:49Z","timestamp":1772114389890,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"DOI":"10.1186\/s12977-025-00673-2","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:58:23Z","timestamp":1772110703000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The KT Jeang retrovirology prize 2025: Carine Van Lint"],"prefix":"10.1186","volume":"23","author":[{"given":"Carine","family":"Van Lint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"12","key":"673_CR1","doi-asserted-by":"publisher","first-page":"7066","DOI":"10.1128\/jvi.65.12.7066-7072.1991","volume":"65","author":"C Van Lint","year":"1991","unstructured":"Van Lint C, Burny A, Verdin E. The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites. J Virol. 1991;65(12):7066. https:\/\/doi.org\/10.1128\/jvi.65.12.7066-7072.1991.","journal-title":"J Virol"},{"issue":"4","key":"673_CR2","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1128\/JVI.68.4.2632-2648.1994","volume":"68","author":"C Van Lint","year":"1994","unstructured":"Van Lint C, Ghysdael J, Paras P, Burny A, Verdin EA. Transcriptional regulatory element is associated with a Nuclease-Hypersensitive site in the pol gene of human immunodeficiency virus type 1. J Virol. 1994;68(4):2632\u201348. https:\/\/doi.org\/10.1128\/JVI.68.4.2632-2648.1994.","journal-title":"J Virol"},{"key":"673_CR3","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1002\/j.1460-2075.1993.tb05994.x","volume":"12 8","author":"E Verdin","year":"1993","unstructured":"Verdin E, Paras P, Van Lint C. Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J. 1993;12 8:3249\u201359. https:\/\/doi.org\/10.1002\/j.1460-2075.1993.tb05994.x.","journal-title":"EMBO J"},{"issue":"5","key":"673_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/j.1460-2075.1996.tb00449.x","volume":"15","author":"C Van Lint","year":"1996","unstructured":"Van Lint C, Emiliani S, Ott M, Verdin E. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J. 1996;15(5):1112\u201320. https:\/\/doi.org\/10.1002\/j.1460-2075.1996.tb00449.x.","journal-title":"EMBO J"},{"issue":"8","key":"673_CR5","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1128\/jvi.71.8.6113-6127.1997","volume":"71","author":"C Van Lint","year":"1997","unstructured":"Van Lint C, Amella CA, Emiliani S, John M, Jie T, Verdin E. Transcription factor binding sites downstream of the human immunodeficiency virus type 1 transcription start site are important for virus infectivity. J Virol. 1997;71(8):6113\u201327. https:\/\/doi.org\/10.1128\/jvi.71.8.6113-6127.1997.","journal-title":"J Virol"},{"issue":"13","key":"673_CR6","doi-asserted-by":"publisher","first-page":"6377","DOI":"10.1073\/pnas.93.13.6377","volume":"93","author":"S Emiliani","year":"1996","unstructured":"Emiliani S, Van Lint C, Fischle W, Paras P, Ott M, Brady J, Verdin E. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc Natl Acad Sci. 1996;93(13):6377\u201381. https:\/\/doi.org\/10.1073\/pnas.93.13.6377.","journal-title":"Proc Natl Acad Sci"},{"issue":"5305","key":"673_CR7","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1126\/science.275.5305.1481","volume":"275","author":"M Ott","year":"1997","unstructured":"Ott M, Emiliani S, Van Lint C, Herbein G, Lovett J, Chirmule N, McCloskey T, Pahwa S, Verdin E. Immune hyperactivation of HIV-1-Infected T cells mediated by Tat and the CD28 pathway. Science. 1997;275(5305):1481\u20135. https:\/\/doi.org\/10.1126\/science.275.5305.1481.","journal-title":"Science"},{"issue":"1","key":"673_CR8","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1128\/jvi.72.1.660-670.1998","volume":"72","author":"G Herbein","year":"1998","unstructured":"Herbein G, Van Lint C, Lovett JL, Verdin E. Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-Infected and in uninfected bystander T lymphocytes. J Virol. 1998;72(1):660\u201370. https:\/\/doi.org\/10.1128\/jvi.72.1.660-670.1998.","journal-title":"J Virol"},{"issue":"2","key":"673_CR9","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1128\/jvi.72.2.1666-1670.1998","volume":"72","author":"S Emiliani","year":"1998","unstructured":"Emiliani S, Fischle W, Ott M, Van Lint C, Amella CA, Verdin E. Mutations in the Tat gene are responsible for human immunodeficiency virus type 1 postintegration latency in the U1 cell line. J Virol. 1998;72(2):1666\u201370. https:\/\/doi.org\/10.1128\/jvi.72.2.1666-1670.1998.","journal-title":"J Virol"},{"issue":"6","key":"673_CR10","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.1073\/pnas.95.6.2795","volume":"95","author":"S Emiliani","year":"1998","unstructured":"Emiliani S, Fischle W, Van Lint C, Al-Abed Y, Verdin E. Characterization of a human RPD3 ortholog, HDAC3. Proc Natl Acad Sci. 1998;95(6):2795\u2013800. https:\/\/doi.org\/10.1073\/pnas.95.6.2795.","journal-title":"Proc Natl Acad Sci"},{"issue":"21","key":"673_CR11","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.1128\/jvi.76.21.11091-11103.2002","volume":"76","author":"V Quivy","year":"2002","unstructured":"Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C, Berkhout B, Castellano R, de Launoit Y, Burny A, Piette J, Bours V, Van Lint C. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-\u03baB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J Virol. 2002;76(21):11091\u2013103. https:\/\/doi.org\/10.1128\/jvi.76.21.11091-11103.2002.","journal-title":"J Virol"},{"issue":"17","key":"673_CR12","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1128\/MCB.23.17.6200-6209.2003","volume":"23","author":"E Adam","year":"2003","unstructured":"Adam E, Quivy V, Bex F, Chariot A, Collette Y, Vanhulle C, Schoonbroodt S, Goffin V, Nguy\u00ean TL-A, Gloire G, Carrard G, Friguet B, de Launoit Y, Burny A, Bours V, Piette J, Van Lint C. Potentiation of tumor necrosis Factor-Induced NF-\u03baB activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I\u03baB\u03b1. Mol Cell Biol. 2003;23(17):6200\u20139. https:\/\/doi.org\/10.1128\/MCB.23.17.6200-6209.2003.","journal-title":"Mol Cell Biol"},{"key":"673_CR13","doi-asserted-by":"crossref","unstructured":"Calao M, Burny A, Quivy V, Dekoninck A, Van Lint C. A pervasive role of histone-acetyltransferases and -deacetylases in an NF-kB-signaling code. Trends Biochem Sci. 2008 Jul;33(7):339-49. doi: 10.1016\/j.tibs.2008.04.015.","DOI":"10.1016\/j.tibs.2008.04.015"},{"issue":"27","key":"673_CR14","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1038\/sj.onc.1202776","volume":"18","author":"A Chariot","year":"1999","unstructured":"Chariot A, Van Lint C, Chapelier M, Gielen J, Merville M-P, Bours V. CBP and histone deacetylase Inhibition enhance the transactivation potential of the HOXB7 homeodomain-containing protein. Oncogene. 1999;18(27):4007\u201314. https:\/\/doi.org\/10.1038\/sj.onc.1202776.","journal-title":"Oncogene"},{"issue":"4","key":"673_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.celrep.2014.12.047","volume":"10","author":"D Sauter","year":"2015","unstructured":"Sauter D, Hotter D, Van Driessche B, St\u00fcrzel CM, Kluge SF, Wildum S, Yu H, Baumann B, Wirth T, Plantier J-C, Leoz M, Hahn BH, Van Lint C, Kirchhoff F. Differential regulation of NF-\u03baB-mediated proviral and antiviral host gene expression by primate lentiviral Nef and Vpu proteins. Cell Rep. 2015;10(4):586\u201399. https:\/\/doi.org\/10.1016\/j.celrep.2014.12.047.","journal-title":"Cell Rep"},{"key":"673_CR16","doi-asserted-by":"publisher","first-page":"8e1006598","DOI":"10.1371\/journal.ppat.1006598","volume":"13","author":"D Hotter","year":"2017","unstructured":"Hotter D, Krabbe T, Reith E, Gawanbacht A, Rahm N, Ayouba A, Van Driessche B, Van Lint C, Peeters M, Kirchhoff F, Sauter D. Primate lentiviruses use at least three alternative strategies to suppress NF-\u03baB-Mediated immune activation. PLoS Pathog. 2017;13:8e1006598. https:\/\/doi.org\/10.1371\/journal.ppat.1006598.","journal-title":"PLoS Pathog"},{"issue":"21","key":"673_CR17","doi-asserted-by":"publisher","first-page":"6106","DOI":"10.1093\/emboj\/18.21.6106","volume":"18","author":"RE Kiernan","year":"1999","unstructured":"Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F, Calomme C, Burny A, Nakatani Y, Jeang KT, Benkirane M, Van Lint C. HIV-1 Tat transcriptional activity is regulated by acetylation. EMBO J. 1999;18(21):6106\u201318. https:\/\/doi.org\/10.1093\/emboj\/18.21.6106.","journal-title":"EMBO J"},{"issue":"14","key":"673_CR18","doi-asserted-by":"publisher","first-page":"12310","DOI":"10.1074\/jbc.M211167200","volume":"278","author":"R Harrod","year":"2003","unstructured":"Harrod R, Nacsa J, Van Lint C, Hansen J, Karpova T, McNally J, Franchini G. Human immunodeficiency virus yype-1 Tat\/Co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-Responsive transcription. J Biol Chem. 2003;278(14):12310\u20138. . https:\/\/doi.org\/10.1074\/jbc.M211167200","journal-title":"J Biol Chem"},{"issue":"4","key":"673_CR19","doi-asserted-by":"publisher","first-page":"e19084","DOI":"10.1371\/journal.pone.0019084","volume":"6","author":"L Colin","year":"2011","unstructured":"Colin L, Vandenhoudt N, De Walque S, Van Driessche B, Bergamaschi A, Martinelli V, Cherrier T, Vanhulle C, Guiguen A, David A, Burny A, Herbein G, Pancino G, Rohr O, Van Lint C. The AP-1 binding sites located in the pol gene intragenic regulatory region of HIV-1 are important for viral replication. PLoS ONE. 2011;6(4):e19084. . https:\/\/doi.org\/10.1371\/journal.pone.0019084","journal-title":"PLoS ONE"},{"issue":"13","key":"673_CR20","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1093\/nar\/gki720","volume":"33","author":"V Goffin","year":"2005","unstructured":"Goffin V, Demont\u00e9 D, Vanhulle C, de Walque S, de Launoit Y, Burny A, Collette Y, Van Lint C. Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivity. Nucleic Acids Res. 2005;33(13):4285\u2013310. . https:\/\/doi.org\/10.1093\/nar\/gki720","journal-title":"Nucleic Acids Res"},{"issue":"21","key":"673_CR21","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.1074\/jbc.M602373200","volume":"281","author":"R Castellano","year":"2006","unstructured":"Castellano R, Vire B, Pion M, Quivy V, Olive D, Hirsch I, Van Lint C, Collette Y. Active transcription of the human FASL\/CD95L\/TNFSF6 promoter region in T lymphocytes involves chromatin remodeling. J Biol Chem. 2006;281(21):14719\u201328. https:\/\/doi.org\/10.1074\/jbc.M602373200.","journal-title":"J Biol Chem"},{"issue":"12","key":"673_CR22","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1182\/blood-2002-09-2851","volume":"101","author":"S Goriely","year":"2003","unstructured":"Goriely S, Demont\u00e9 D, Nizet S, De Wit D, Willems F, Goldman M, Van Lint C. Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites. Blood. 2003;101(12):4894\u2013902. . https:\/\/doi.org\/10.1182\/blood-2002-09-2851","journal-title":"Blood"},{"issue":"7","key":"673_CR23","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1084\/jem.20031272","volume":"199","author":"S Goriely","year":"2004","unstructured":"Goriely S, Van Lint C, Dadkhah R, Libin M, De Wit D, Demont\u00e9 D, Willems F, Goldman M. A defect in nucleosome remodeling prevents IL-12 (p35) gene transcription in neonatal dendritic cells. J Exp Med. 2004;199(7):1011\u20136. . https:\/\/doi.org\/10.1084\/jem.20031272","journal-title":"J Exp Med"},{"issue":"20","key":"673_CR24","doi-asserted-by":"publisher","first-page":"5488","DOI":"10.1128\/MCB.01657-08","volume":"29","author":"N Ndlovu","year":"2009","unstructured":"Ndlovu N, Van Lint M, Van Wesemael C, Callebert K, Chalbos P, Haegeman D, Vanden Berghe G. Hyperactivated NF-\u03baB and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the Interleukin-6 gene promoter in metastatic breast cancer cells. Mol Cell Biol. 2009;29(20):5488\u2013504. https:\/\/doi.org\/10.1128\/MCB.01657-08.","journal-title":"Mol Cell Biol"},{"key":"673_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1742-4690-10-67","volume":"10","author":"C Van Lint","year":"2013","unstructured":"Van Lint C, Bouchat S, Marcello A. HIV-1 transcription and latency: an update. Retrovirology. 2013;10:67. https:\/\/doi.org\/10.1186\/1742-4690-10-67.","journal-title":"Retrovirology"},{"key":"673_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/82_2017_74","volume":"417","author":"G Darcis","year":"2018","unstructured":"Darcis G, Van Driessche B, Bouchat S, Kirchhoff F, Van Lint C. Molecular control of HIV and SIV latency. Curr Top Microbiol Immunol. 2018;417:1\u201322. https:\/\/doi.org\/10.1007\/82_2017_74.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"673_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00281-020-00783-3","volume":"42","author":"UC Lange","year":"2020","unstructured":"Lange UC, Verdikt R, Ait-Ammar A, Van Lint C. Epigenetic crosstalk in chronic infection with HIV-1. Semin Immunopathol. 2020;42(2):187\u2013200. https:\/\/doi.org\/10.1007\/s00281-020-00783-3.","journal-title":"Semin Immunopathol"},{"issue":"12","key":"673_CR28","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.3390\/v12121385","volume":"12","author":"A Dutilleul","year":"2020","unstructured":"Dutilleul A, Rodari A, Van Lint C. Depicting HIV-1 transcriptional mechanisms: a summary of what we know. Viruses. 2020;12(12):1385. https:\/\/doi.org\/10.3390\/v12121385.","journal-title":"Viruses"},{"issue":"5","key":"673_CR29","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/vaccines9050514","volume":"9","author":"R Verdikt","year":"2021","unstructured":"Verdikt R, Hernalsteens O, Van Lint C. Epigenetic mechanisms of HIV-1 persistence. Vaccines. 2021;9(5):514. https:\/\/doi.org\/10.3390\/vaccines9050514.","journal-title":"Vaccines"},{"issue":"5988","key":"673_CR30","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1126\/science.1191047","volume":"329","author":"D Trono","year":"2010","unstructured":"Trono D, Van Lint C, Rouzioux C, Verdin E, Barr\u00e9-Sinoussi F, Chun T-W, Chomont N. HIV Persistence and the prospect of long-term drug-free remissions for HIV-infected individuals. Science. 2010;329(5988):174\u201380. . https:\/\/doi.org\/10.1126\/science.1191047","journal-title":"Science"},{"issue":"8","key":"673_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3262","volume":"12","author":"AIDS International","year":"2012","unstructured":"International AIDS, Society Scientific Working Group on HIV Cure, Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, Chun T-W, Churchill M, Di Mascio M, Katlama C, Lafeuillade A, Landay A, Lederman M, Lewin SR, Maldarelli F, Margolis D, Markowitz M, Martinez-Picado J, Mullins JI, Mellors J, Moreno S, O\u2019Doherty U, Palmer S, Penicaud M-C, Peterlin M, Poli G, Routy J-P, Rouzioux C, Silvestri G, Stevenson M, Telenti A, Van Lint C, Verdin E, Woolfrey A, Zaia J, Barr\u00e9-Sinoussi F. Towards an HIV cure: a global scientific strategy. Nat Rev Immunol. 2012;12(8):607\u201314. https:\/\/doi.org\/10.1038\/nri3262.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"673_CR32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/COH.0000000000000288","volume":"11","author":"G Darcis","year":"2016","unstructured":"Darcis G, Van Driessche B, Van Lint C. Preclinical shock strategies to reactivate latent HIV-1: an update. Curr Opin HIV AIDS. 2016;11(4):388. https:\/\/doi.org\/10.1097\/COH.0000000000000288.","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"673_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.it.2016.12.003","volume":"38","author":"G Darcis","year":"2017","unstructured":"Darcis G, Van Driessche B, Van Lint C. HIV Latency. Should we shock or lock? Trends Immunol. 2017;38(3):217\u201328. . https:\/\/doi.org\/10.1016\/j.it.2016.12.003","journal-title":"Trends Immunol"},{"key":"673_CR34","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.3389\/fmicb.2019.03060","volume":"10","author":"A Ait-Ammar","year":"2020","unstructured":"Ait-Ammar A, Kula A, Darcis G, Verdikt R, De Wit S, Gautier V, Mallon PWG, Marcello A, Rohr O, Van Lint C. Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs. Front Microbiol. 2020;10:3060. https:\/\/doi.org\/10.3389\/fmicb.2019.03060.","journal-title":"Front Microbiol"},{"key":"673_CR35","doi-asserted-by":"publisher","first-page":"101478","DOI":"10.1016\/j.smim.2021.101478","volume":"51","author":"A Kula-Pacurar","year":"2021","unstructured":"Kula-Pacurar A, Rodari A, Darcis G, Van Lint C. Shocking HIV-1 with immunomodulatory latency reversing agents. Semin Immunol. 2021;51:101478. https:\/\/doi.org\/10.1016\/j.smim.2021.101478.","journal-title":"Semin Immunol"},{"issue":"8, 2021","key":"673_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev-virology-091919-103029","volume":"8","author":"A Rodari","year":"2021","unstructured":"Rodari A, Darcis G, Van Lint C. The current status of latency reversing agents for HIV-1 remission. Annual Rev Virol. 2021;8(8, 2021):491\u2013514. https:\/\/doi.org\/10.1146\/annurev-virology-091919-103029.","journal-title":"Annual Rev Virol"},{"issue":"1","key":"673_CR37","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/COH.0000000000000993","volume":"21","author":"M Bendoumou","year":"2026","unstructured":"Bendoumou M, Van Lint C. Latency-reversing agents: where are we now? Curr Opin HIV AIDS. 2026;21(1):9. https:\/\/doi.org\/10.1097\/COH.0000000000000993.","journal-title":"Curr Opin HIV AIDS"},{"issue":"6","key":"673_CR38","doi-asserted-by":"publisher","first-page":"e6093","DOI":"10.1371\/journal.pone.0006093","volume":"4","author":"S Reuse","year":"2009","unstructured":"Reuse S, Calao M, Kabeya K, Guiguen A, Gatot J-S, Quivy V, Vanhulle C, Lamine A, Vaira D, Demonte D, Martinelli V, Veithen E, Cherrier T, Avettand V, Poutrel S, Piette J, Launoit Y, Moutschen M, Burny A, Rouzioux C, Wit SD, Herbein G, Rohr O, Collette Y, Lambotte O, Clumeck N, Van Lint C. Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection. PLoS ONE. 2009;4(6):e6093. https:\/\/doi.org\/10.1371\/journal.pone.0006093.","journal-title":"PLoS ONE"},{"issue":"12","key":"673_CR39","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1097\/QAD.0b013e32835535f5","volume":"26","author":"S Bouchat","year":"2012","unstructured":"Bouchat S, Gatot J-S, Kabeya K, Cardona C, Colin L, Herbein G, De Wit S, Clumeck N, Lambotte O, Rouzioux C, Rohr O, Van Lint C. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4\u2009+\u2009T cells from HIV-1-Infected HAART-treated patients. AIDS. 2012;26(12):1473. . https:\/\/doi.org\/10.1097\/QAD.0b013e32835535f5","journal-title":"AIDS"},{"issue":"7","key":"673_CR40","doi-asserted-by":"publisher","first-page":"e1005063","DOI":"10.1371\/journal.ppat.1005063","volume":"11","author":"G Darcis","year":"2015","unstructured":"Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait-Ammar A, Delacourt N, Melard A, Kabeya K, Vanhulle C, Driessche BV, Gatot J-S, Cherrier T, Pianowski LF, Gama L, Schwartz C, Vila J, Burny A, Clumeck N, Moutschen M, De Wit S, Peterlin BM, Rouzioux C, Rohr O. Van Lint C. An in-Depth comparison of latency-Reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified Bryostatin-1\u2009+\u2009JQ1 and ingenol-B\u2009+\u2009JQ1 to potently reactivate viral gene expression. PLoS Pathog. 2015;11(7):e1005063. . https:\/\/doi.org\/10.1371\/journal.ppat.1005063","journal-title":"PLoS Pathog"},{"issue":"2","key":"673_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.15252\/emmm.201505557","volume":"8","author":"S Bouchat","year":"2016","unstructured":"Bouchat S, Delacourt N, Kula A, Darcis G, Van Driessche B, Corazza F, Gatot J, Melard A, Vanhulle C, Kabeya K, Pardons M, Avettand-Fenoel V, Clumeck N, De Wit S, Rohr O, Rouzioux C, Van Lint C. Sequential treatment with 5\u2010aza\u20102\u2032\u2010deoxycytidine and deacetylase inhibitors reactivates HIV\u20101. EMBO Mol Med. 2016;8(2):117\u201338. https:\/\/doi.org\/10.15252\/emmm.201505557.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"673_CR42","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1097\/QAI.0000000000001958","volume":"80","author":"A Kula","year":"2019","unstructured":"Kula A, Delacourt N, Bouchat S, Darcis G, Avettand-Fenoel V, Verdikt R, Corazza F, Necsoi C, Vanhulle C, Bendoumou M, Burny A, De Wit S, Rouzioux C, Rohr O, Van Lint C. Heterogeneous HIV-1 reactivation patterns of disulfiram and combined disulfiram\u2009+\u2009romidepsin treatments. JAIDS J Acquir Immune Defic Syndr. 2019;80(5):605. https:\/\/doi.org\/10.1097\/QAI.0000000000001958.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"2","key":"673_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/QAD.0000000000001290","volume":"31","author":"G Darcis","year":"2017","unstructured":"Darcis G, Bouchat S, Kula A, Van Driessche B, Delacourt N, Vanhulle C, Avettand-Fenoel V, De Wit S, Rohr O, Rouzioux C, Van Lint C. Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir. AIDS. 2017;31(2):181. https:\/\/doi.org\/10.1097\/QAD.0000000000001290.","journal-title":"AIDS"},{"key":"673_CR44","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fcimb.2019.00362","volume":"9","author":"C Wallet","year":"2019","unstructured":"Wallet C, De Rovere M, Van Assche J, Daouad F, De Wit S, Gautier V, Mallon PWG, Marcello A, Van Lint C, Rohr O, Schwartz C. Microglial cells: the main HIV-1 reservoir in the brain. Front Cell Infect Microbiol. 2019;9:362. https:\/\/doi.org\/10.3389\/fcimb.2019.00362.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"673_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/sj.emboj.7601516","volume":"26","author":"C Marban","year":"2007","unstructured":"Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, Van Lint C, Aunis D, Rohr O. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional Silencing. EMBO J. 2007;26(2):412\u201323. https:\/\/doi.org\/10.1038\/sj.emboj.7601516.","journal-title":"EMBO J"},{"issue":"38","key":"673_CR46","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1038\/onc.2009.193","volume":"28","author":"T Cherrier","year":"2009","unstructured":"Cherrier T, Suzanne S, Redel L, Calao M, Marban C, Samah B, Mukerjee R, Schwartz C, Gras G, Sawaya BE, Zeichner SL, Aunis D, Van Lint C. Rohr, O. p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene. 2009;28(38):3380\u20139. . https:\/\/doi.org\/10.1038\/onc.2009.193","journal-title":"Oncogene"},{"issue":"5","key":"673_CR47","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1093\/nar\/gkr857","volume":"40","author":"V Le Douce","year":"2012","unstructured":"Le Douce V, Colin L, Redel L, Cherrier T, Herbein G, Aunis D, Rohr O, Van Lint C, Schwartz C. LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional Silencing. Nucleic Acids Res. 2012;40(5):1904\u201315. https:\/\/doi.org\/10.1093\/nar\/gkr857.","journal-title":"Nucleic Acids Res"},{"issue":"31","key":"673_CR48","doi-asserted-by":"publisher","first-page":"12655","DOI":"10.1073\/pnas.1220136110","volume":"110","author":"T Cherrier","year":"2013","unstructured":"Cherrier T, Le Douce V, Eilebrecht S, Riclet R, Marban C, Dequiedt F, Goumon Y, Paillart J-C, Mericskay M, Parlakian A, Bausero P, Abbas W, Herbein G, Kurdistani SK, Grana X, Van Driessche B, Schwartz C, Candolfi E, Benecke AG, Van Lint C, Rohr O. CTIP2 is a negative regulator of P-TEFb. Proc Natl Acad Sci. 2013;110(31):12655\u201360. https:\/\/doi.org\/10.1073\/pnas.1220136110.","journal-title":"Proc Natl Acad Sci"},{"issue":"8","key":"673_CR49","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.1093\/nar\/gku168","volume":"42","author":"S Eilebrecht","year":"2014","unstructured":"Eilebrecht S, Le Douce V, Riclet R, Targat B, Hallay H, Van Driessche B, Schwartz C, Robette G, Van Lint C, Rohr O, Benecke AG. HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters. Nucleic Acids Res. 2014;42(8):4962\u201371. . https:\/\/doi.org\/10.1093\/nar\/gku168","journal-title":"Nucleic Acids Res"},{"key":"673_CR50","doi-asserted-by":"publisher","first-page":"34920","DOI":"10.1038\/srep34920","volume":"6","author":"V Le Douce","year":"2016","unstructured":"Le Douce V, Forouzanfar F, Eilebrecht S, Van Driessche B, Ait-Ammar A, Verdikt R, Kurashige Y, Marban C, Gautier V, Candolfi E, Benecke AG, Van Lint C, Rohr O, Schwartz C. HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1. Sci Rep. 2016;6:34920. https:\/\/doi.org\/10.1038\/srep34920.","journal-title":"Sci Rep"},{"issue":"1","key":"673_CR51","doi-asserted-by":"publisher","first-page":"13154","DOI":"10.1038\/s41598-019-48689-x","volume":"9","author":"F Forouzanfar","year":"2019","unstructured":"Forouzanfar F, Ali S, Wallet C, De Rovere M, Ducloy C, El Mekdad H, El Maassarani M, A\u00eft-Ammar A, Van Assche J, Boutant E, Daouad F, Margottin-Goguet F, Moog C, Van Lint C, Schwartz C. Rohr, O. HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing. Sci Rep. 2019;9(1):13154. https:\/\/doi.org\/10.1038\/s41598-019-48689-x.","journal-title":"Sci Rep"},{"issue":"1","key":"673_CR52","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41598-021-82164-w","volume":"11","author":"A Ait-Ammar","year":"2021","unstructured":"Ait-Ammar A, Bellefroid M, Daouad F, Martinelli V, Van Assche J, Wallet C, Rodari A, De Rovere M, Fahrenkrog B, Schwartz C, Van Lint C, Gautier V, Rohr O. Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage. Sci Rep. 2021;11(1):2692. https:\/\/doi.org\/10.1038\/s41598-021-82164-w.","journal-title":"Sci Rep"},{"key":"673_CR53","doi-asserted-by":"publisher","unstructured":"Verdikt R, Bendoumou M, Bouchat S, Nestola L, Pasternak AO, Darcis G, Avettand-Fenoel V, Vanhulle C, A\u00eft-Ammar A, Santangelo M, Plant E, Douce VL, Delacourt N, Cicilionyt\u0117 A, Necsoi C, Corazza F, Passaes CPB, Schwartz C, Bizet M, Fuks F, S\u00e1ez-Ciri\u00f3n A, Rouzioux C, De Wit S, Berkhout B, Gautier V, Rohr O, Van Lint C. Novel Role of UHRF1 in the Epigenetic Repression of the Latent HIV-1. EBioMedicine 2022. 79: 103985. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103985","DOI":"10.1016\/j.ebiom.2022.103985"},{"key":"673_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.celrep.2023.112634","volume":"42","author":"D Chatterjee","year":"2023","unstructured":"Chatterjee D, Zhang Y, Ngassaki-Yoka C-D, Dutilleul A, Khalfi S, Hernalsteens O, Salinas TRW, Dias J, Chen H, Smail Y, Goulet J-P, Bell B, Routy J-P, Van Lint C, Ancuta P. Identification of aryl hydrocarbon receptor as a barrier to HIV-1 infection and outgrowth in CD4\u2009+\u2009T cells. Cell Rep. 2023;42:6. https:\/\/doi.org\/10.1016\/j.celrep.2023.112634.","journal-title":"Cell Rep"},{"key":"673_CR55","doi-asserted-by":"publisher","unstructured":"Dias J, Cattin A, Bendoumou M, Dutilleul A, Lodge R, Goulet J-P, Fert A, Marchand LR, Salinas TRW, Yoka C-DN, Gabriel EM, Caballero RE, Routy J-P, Cohen \u00c9A, Van Lint C, Ancuta P. Retinoic acid enhances HIV-1 reverse transcription and transcription in macrophages via mTOR-modulated mechanisms. Cell Rep. 2024.43: 7. https:\/\/doi.org\/10.1016\/j.celrep.2024.114414","DOI":"10.1016\/j.celrep.2024.114414"},{"issue":"6","key":"673_CR56","doi-asserted-by":"publisher","first-page":"e02158","DOI":"10.1128\/mBio.02158-18","volume":"9","author":"A Sarracino","year":"2018","unstructured":"Sarracino A, Gharu L, Kula A, Pasternak AO, Avettand-Fenoel V, Rouzioux C, Bardina M, De Wit S, Benkirane M, Berkhout B, Van Lint C, Marcello A. Posttranscriptional regulation of HIV-1 gene expression during replication and reactivation from latency by nuclear matrix protein MATR3. mBio. 2018;9(6):e02158\u201318. https:\/\/doi.org\/10.1128\/mBio.02158-18.","journal-title":"mBio"},{"issue":"1","key":"673_CR57","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/s41467-025-57290-y","volume":"16","author":"A Dorman","year":"2025","unstructured":"Dorman A, Bendoumou M, Valaitien\u0117 A, Wadas J, Ali H, Dutilleul A, Maiuri P, Nestola L, Bociaga-Jasik M, Mchantaf G, Necsoi C, De Wit S, Avettand-Feno\u00ebl V, Marcello A, Pyrc K, Pasternak AO, Van Lint C, Kula-Pacurar A. Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latency. Nat Commun. 2025;16(1):2078. https:\/\/doi.org\/10.1038\/s41467-025-57290-y.","journal-title":"Nat Commun"},{"issue":"1","key":"673_CR58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12985-025-02744-4","volume":"22","author":"H Ali","year":"2025","unstructured":"Ali H, Wadas J, Bendoumou M, Chen H-C, Maiuri P, Dutilleul A, Selberg S, Nestola L, Lalik K, Avettand-Feno\u00ebl V, Necsoi C, Marcello A, Kankuri E, Karelson M, De Wit S, Pyrc K, Pasternak AO, Van Lint C, Kula-Pacurar A. Inhibition of ALKBH5 demethylase of m6A pathway potentiates HIV-1 reactivation from latency. Virol J. 2025;22(1):124. https:\/\/doi.org\/10.1186\/s12985-025-02744-4.","journal-title":"Virol J"},{"issue":"1","key":"673_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12977-023-00623-w","volume":"20","author":"E Plant","year":"2023","unstructured":"Plant E, Bellefroid M, Van Lint C. A complex network of transcription factors and epigenetic regulators involved in bovine leukemia virus transcriptional regulation. Retrovirology. 2023;20(1):11. . https:\/\/doi.org\/10.1186\/s12977-023-00623-w","journal-title":"Retrovirology"},{"issue":"29","key":"673_CR60","doi-asserted-by":"publisher","first-page":"20854","DOI":"10.1074\/jbc.M703060200","volume":"282","author":"TL-A Nguy\u00ean","year":"2007","unstructured":"Nguy\u00ean TL-A, de Walque S, Veithen E, Dekoninck A, Martinelli V, de Launoit Y, Burny A, Harrod R, Van Lint C. Transcriptional regulation of the bovine leukemia virus promoter by the cyclic AMP-response element modulator Tau isoform. J Biol Chem. 2007;282(29):20854\u201367. https:\/\/doi.org\/10.1074\/jbc.M703060200.","journal-title":"J Biol Chem"},{"issue":"19","key":"673_CR61","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1038\/sj.onc.1206392","volume":"22","author":"A Dekoninck","year":"2003","unstructured":"Dekoninck A, Calomme C, Nizet S, de Launoit Y, Burny A, Ghysdael J, Van Lint C. Identification and characterization of a PU.1\/Spi-B binding site in the bovine leukemia virus long terminal repeat. Oncogene. 2003;22(19):2882\u201396. https:\/\/doi.org\/10.1038\/sj.onc.1206392.","journal-title":"Oncogene"},{"issue":"11","key":"673_CR62","doi-asserted-by":"publisher","first-page":"8775","DOI":"10.1074\/jbc.M107441200","volume":"277","author":"C Calomme","year":"2002","unstructured":"Calomme C, Nguyen TL-A, de Launoit Y, Kiermer V, Droogmans L, Burny A, Van Lint C. Upstream stimulatory factors binding to an E box motif in the R region of the bovine leukemia virus long terminal repeat stimulates viral gene expression. J Biol Chem. 2002;277(11):8775\u201389. https:\/\/doi.org\/10.1074\/jbc.M107441200.","journal-title":"J Biol Chem"},{"issue":"7","key":"673_CR63","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1128\/JVI.72.7.5526-5534.1998","volume":"72","author":"V Kiermer","year":"1998","unstructured":"Kiermer V, Van Lint C, Briclet D, Vanhulle C, Kettmann R, Verdin E, Burny A, Droogmans L. An interferon regulatory factor binding site in the U5 region of the bovine leukemia virus long terminal repeat stimulates tax-independent gene expression. J Virol. 1998;72(7):5526\u201334. https:\/\/doi.org\/10.1128\/JVI.72.7.5526-5534.1998.","journal-title":"J Virol"},{"issue":"10","key":"673_CR64","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1128\/jvi.76.10.5034-5042.2002","volume":"76","author":"C Merezak","year":"2002","unstructured":"Merezak C, Reichert M, Van Lint C, Kerkhofs P, Portetelle D, Willems L, Kettmann R. Inhibition of histone deacetylases induces bovine leukemia virus expression in vitro and in vivo. J Virol. 2002;76(10):5034\u201342. https:\/\/doi.org\/10.1128\/jvi.76.10.5034-5042.2002.","journal-title":"J Virol"},{"issue":"24","key":"673_CR65","doi-asserted-by":"publisher","first-page":"13848","DOI":"10.1128\/JVI.78.24.13848-13864.2004","volume":"78","author":"C Calomme","year":"2004","unstructured":"Calomme C, Dekoninck A, Nizet S, Adam E, Nguy\u00ean TL-A, Van Den Broeke A, Willems L, Kettmann R, Burny A, Van Lint C. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5\u2019 long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency. J Virol. 2004;78(24):13848\u201364. . https:\/\/doi.org\/10.1128\/JVI.78.24.13848-13864.2004","journal-title":"J Virol"},{"issue":"33","key":"673_CR66","doi-asserted-by":"publisher","first-page":"35025","DOI":"10.1074\/jbc.M404081200","volume":"279","author":"TL-A Nguy\u00ean","year":"2004","unstructured":"Nguy\u00ean TL-A, Calomme C, Wijmeersch G, Nizet S, Veithen E, Portetelle D, de Launoit Y, Burny A, Van Lint C. Deacetylase inhibitors and the viral transactivator TaxBLV synergistically activate bovine leukemia virus gene expression via a cAMP-responsive element- and cAMP-responsive element-binding protein-dependent mechanism. J Biol Chem. 2004;279(33):35025\u201336. https:\/\/doi.org\/10.1074\/jbc.M404081200.","journal-title":"J Biol Chem"},{"issue":"25","key":"673_CR67","doi-asserted-by":"publisher","first-page":"19434","DOI":"10.1074\/jbc.M110.107607","volume":"285","author":"V Pierard","year":"2010","unstructured":"Pierard V, Guiguen A, Colin L, Wijmeersch G, Vanhulle C, Van Driessche B, Dekoninck A, Blazkova J, Cardona C, Merimi M, Vierendeel V, Calomme C, Nguy\u00ean TL-A, Nuttinck M, Twizere J-C, Kettmann R, Portetelle D, Burny A, Hirsch I, Rohr O, Van Lint C. DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct Inhibition of cAMP-responsive element CRE-binding protein\/CRE modulator\/activation transcription factor binding. J Biol Chem. 2010;285(25):19434\u201349. . https:\/\/doi.org\/10.1074\/jbc.M110.107607","journal-title":"J Biol Chem"},{"issue":"22","key":"673_CR68","doi-asserted-by":"publisher","first-page":"9559","DOI":"10.1093\/nar\/gkr671","volume":"39","author":"L Colin","year":"2011","unstructured":"Colin L, Dekoninck A, Reichert M, Calao M, Merimi M, Van den Broeke A, Vierendeel V, Cleuter Y, Burny A, Rohr O, Van Lint C. Chromatin disruption in the promoter of bovine leukemia virus during transcriptional activation. Nucleic Acids Res. 2011;39(22):9559\u201373. https:\/\/doi.org\/10.1093\/nar\/gkr671.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"673_CR69","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1073\/pnas.1213842110","volume":"110","author":"N Rosewick","year":"2013","unstructured":"Rosewick N, Momont M, Durkin K, Takeda H, Caiment F, Cleuter Y, Vernin C, Mortreux F, Wattel E, Burny A, Georges M, Van den Broeke A. Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-Cell Leukemia\/Lymphoma. Proc Natl Acad Sci U S A. 2013;110(6):2306\u201311. . https:\/\/doi.org\/10.1073\/pnas.1213842110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"673_CR70","doi-asserted-by":"publisher","first-page":"31125","DOI":"10.1038\/srep31125","volume":"6","author":"B Van Driessche","year":"2016","unstructured":"Van Driessche B, Rodari A, Delacourt N, Fauquenoy S, Vanhulle C, Burny A, Rohr O, Van Lint C. Characterization of new RNA polymerase III and RNA polymerase II transcriptional promoters in the bovine leukemia virus genome. Sci Rep. 2016;6(1):31125. https:\/\/doi.org\/10.1038\/srep31125.","journal-title":"Sci Rep"},{"issue":"6","key":"673_CR71","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1093\/nar\/gkac107","volume":"50","author":"M Bellefroid","year":"2022","unstructured":"Bellefroid M, Rodari A, Galais M, Krijger PHL, Tjalsma SJD, Nestola L, Plant E, Vos ESM, Cristinelli S, Van Driessche B, Vanhulle C, Ait-Ammar A, Burny A, Ciuffi A, de Laat W, Van Lint C. Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization. Nucleic Acids Res. 2022;50(6):3190\u2013202. https:\/\/doi.org\/10.1093\/nar\/gkac107.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"673_CR72","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1182\/blood-2006-06-026781","volume":"109","author":"J-C Twizere","year":"2006","unstructured":"Twizere J-C, Springael J-Y, Boxus M, Burny A, Dequiedt F, Dewulf J-F, Duchateau J, Portetelle D, Urbain P, Van Lint C, Green PL, Mahieux R, Parmentier M, Willems L, Kettmann R. Human T-cell leukemia virus type-1 tax oncoprotein regulates G-protein signaling. Blood. 2006;109(3):1051\u201360. https:\/\/doi.org\/10.1182\/blood-2006-06-026781.","journal-title":"Blood"},{"key":"673_CR73","doi-asserted-by":"publisher","unstructured":"Legros S, Boxus M, Gatot JS, Van Lint C, Kruys V, Kettmann R, Twizere JC, Dequiedt F. The HTLV-1 tax protein inhibits formation of stress granules by interacting with histone deacetylase 6. Oncogene. 2011. 38: 4050\u20134062. https:\/\/doi.org\/10.1038\/onc.2011.120","DOI":"10.1038\/onc.2011.120"},{"key":"673_CR74","doi-asserted-by":"crossref","unstructured":"Simonis N, Rual JF, Lemmens I, Boxus M, Hirozane-Kishikawa T, Gatot JS, Dricot A, Hao T, Vertommen D, Legros S, Daakour S, Klitgord N, Martin M, Willaert JF, Dequiedt F, Navratil V, Cusick ME, Burny A, Van Lint C, Hill DE, Tavernier J, Kettmann R, Vidal M, Twizere JC. Host-Pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology. 2012. Mar 29;9:26. doi: 10.1186\/1742-4690-9-26.","DOI":"10.1186\/1742-4690-9-26"},{"key":"673_CR75","doi-asserted-by":"publisher","first-page":"105675","DOI":"10.1016\/j.antiviral.2023.105675","volume":"217","author":"SB Maseko","year":"2023","unstructured":"Maseko SB, Brammerloo Y, Van Molle I, Sogues A, Martin C, Gorgulla C, Plant E, Olivet J, Blavier J, Ntombela T, Delvigne F, Arthanari H, El Hajj H, Bazarbachi A, Van Lint C, Salehi-Ashtiani K, Remaut H, Ballet S, Volkov AN, Twizere J-C. Identification of small molecule antivirals against HTLV-1 by targeting the hDLG1-tax-1 protein-protein interaction. Antiviral Res. 2023;217:105675. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105675.","journal-title":"Antiviral Res"},{"key":"673_CR76","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.virol.2019.07.003","volume":"535","author":"A Malu","year":"2019","unstructured":"Malu A, Hutchison T, Yapindi L, Smith K, Nelson K, Bergeson R, Pope J, Romeo M, Harrod C, Ratner L, Van Lint C, Harrod R. The human T-cell leukemia virus type-1 tax oncoprotein dissociates NF-\u03baB p65RelA-stathmin complexes and causes catastrophic mitotic spindle damage and genomic instability. Virology. 2019;535:83\u2013101. . https:\/\/doi.org\/10.1016\/j.virol.2019.07.003","journal-title":"Virology"},{"issue":"1","key":"673_CR77","doi-asserted-by":"publisher","first-page":"43221","DOI":"10.1038\/srep43221","volume":"7","author":"S Fauquenoy","year":"2017","unstructured":"Fauquenoy S, Robette G, Kula A, Vanhulle C, Bouchat S, Delacourt N, Rodari A, Marban C, Schwartz C, Burny A, Rohr O, Van Driessche B, Van Lint C. Repression of human T-Lymphotropic virus type 1 long terminal repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites. Sci Rep. 2017;7(1):43221. https:\/\/doi.org\/10.1038\/srep43221.","journal-title":"Sci Rep"},{"issue":"9","key":"673_CR78","doi-asserted-by":"publisher","first-page":"e1013448","DOI":"10.1371\/journal.ppat.1013448","volume":"21","author":"AS Chasseur","year":"2025","unstructured":"Chasseur AS, Bellefroid M, Galais M, Gong M, Lombard P, Mathieu S, Pecquet A, Plant E, Ponsard C, Vreux L, Yague-Sanz C, Dewals BG, Gillet NA, Muylkens B, Van Lint C, Coupeau D. Unbiased and comprehensive identification of virus-derived circular RNAs in a large range of viral species and families. PLoS Pathog. 2025;21(9):e1013448. https:\/\/doi.org\/10.1371\/journal.ppat.1013448.","journal-title":"PLoS Pathog"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-025-00673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12977-025-00673-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-025-00673-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:58:25Z","timestamp":1772110705000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12977-025-00673-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1186\/s12977-025-00673-2","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"26 February 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Carine Van Lint is an Associate Editor for Retrovirology.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}